BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7908645)

  • 1. Noradrenaline but not dopamine involved in NMDA receptor-mediated hyperalgesia induced by theophylline in awake rats.
    Paalzow GH
    Eur J Pharmacol; 1994 Jan; 252(1):87-97. PubMed ID: 7908645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relative importance of dopamine and noradrenaline receptor stimulation for the restoration of motor activity in reserpine or alpha-methyl-p-tyrosine pre-treated mice.
    Dolphin AC; Jenner P; Marsden CD
    Pharmacol Biochem Behav; 1976 Jun; 4(6):661-70. PubMed ID: 981283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of dopamine in regulation of thyrotropin-releasing hormone in the striatum and nucleus accumbens of the rat.
    Przegaliński E; Jaworska L; Konarska R; Gołembiowska K
    Neuropeptides; 1991 Jul; 19(3):189-95. PubMed ID: 1680223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postsynaptic dopamine/adenosine interaction: II. Postsynaptic dopamine agonism and adenosine antagonism of methylxanthines in short-term reserpinized mice.
    Ferré S; Herrera-Marschitz M; Grabowska-Andén M; Casas M; Ungerstedt U; Andén NE
    Eur J Pharmacol; 1991 Jan; 192(1):31-7. PubMed ID: 1828237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. L-dopa induces opposing effects on pain in intact rats: (-)-sulpiride, SCH 23390 or alpha-methyl-DL-p-tyrosine methylester hydrochloride reveals profound hyperalgesia in large antinociceptive doses.
    Paalzow GH
    J Pharmacol Exp Ther; 1992 Nov; 263(2):470-9. PubMed ID: 1432683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The thermogenic actions of alpha 2-adrenoceptor agonists in reserpinized mice are mediated via a central postsynaptic alpha 2-adrenoceptor mechanism.
    Bill DJ; Hughes IE; Stephens RJ
    Br J Pharmacol; 1989 Jan; 96(1):133-43. PubMed ID: 2564288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postsynaptic dopamine/adenosine interaction: I. Adenosine analogues inhibit dopamine D2-mediated behaviour in short-term reserpinized mice.
    Ferré S; Herrera-Marschitz M; Grabowska-Andén M; Ungerstedt U; Casas M; Andén NE
    Eur J Pharmacol; 1991 Jan; 192(1):25-30. PubMed ID: 1828236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On the role of the central noradrenergic and dopaminergic systems in the regulation of TSH secretion in the rat.
    Krulich L; Giachetti A; Marchlewska-Koj A; Hefco E; Jameson HE
    Endocrinology; 1977 Feb; 100(2):496-505. PubMed ID: 188629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cocaine releases limbic acetylcholine through endogenous dopamine action on D1 receptors.
    Imperato A; Obinu MC; Demontis MV; Gessa GL
    Eur J Pharmacol; 1992 Dec; 229(2-3):265-7. PubMed ID: 1362707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of N-methyl-D-aspartate receptors in dopamine D1-, but not D2-, mediated changes in striatal and accumbens neurotensin systems.
    Singh NA; Bush LG; Gibb JW; Hanson GR
    Brain Res; 1992 Feb; 571(2):260-4. PubMed ID: 1351780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Locomotor hyperactivity induced by MK-801 in rats.
    Maj J; Rogóz Z; Skuza G
    Pol J Pharmacol Pharm; 1991; 43(6):449-58. PubMed ID: 1687944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. D1 receptor stimulation inhibits dopamine cell activity after reserpine treatment but not after chronic SCH 23390: an effect blocked by N-methyl-D-aspartate antagonists.
    Huang KX; Walters JR
    J Pharmacol Exp Ther; 1992 Jan; 260(1):409-16. PubMed ID: 1530977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mode of action of bromocriptine following pretreatment with reserpine and alpha-methyl-p-tyrosine in rats.
    Ushijima I; Mizuki Y; Yamada M
    Psychopharmacology (Berl); 1988; 95(1):29-33. PubMed ID: 2898789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noradrenaline-induced emesis. Alpha-2 adrenoceptor mediation in the area postrema.
    Beleslin DB; Strbac M
    Neuropharmacology; 1987 Aug; 26(8):1157-65. PubMed ID: 2889165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bromocriptine-induced hypothermia: D-2 receptor involvement.
    Zarrindast MR; Mahmoudi M
    Arch Int Pharmacodyn Ther; 1989; 298():38-49. PubMed ID: 2569299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenosine A1 and non-A1 receptors: intracellular analysis of the actions of adenosine agonists and antagonists in rat hippocampal neurons.
    Ameri A; Jurna I
    Brain Res; 1991 Apr; 546(1):69-78. PubMed ID: 1855150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antinociception produced by interactions between intrathecally administered adenosine agonists and norepinephrine.
    Aran S; Proudfit HK
    Brain Res; 1990 Apr; 513(2):255-63. PubMed ID: 2350696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular effects of adenosine A2 agonists in the conscious spontaneously hypertensive rat: a comparative study of three structurally distinct ligands.
    Webb RL; Barclay BW; Graybill SC
    J Pharmacol Exp Ther; 1991 Dec; 259(3):1203-12. PubMed ID: 1684818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mode of antinociceptive action of flupirtine in the rat.
    Szelenyi I; Nickel B; Borbe HO; Brune K
    Br J Pharmacol; 1989 Jul; 97(3):835-42. PubMed ID: 2569346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antinociceptive interactions between intrathecally administered alpha noradrenergic agonists and 5'-N-ethylcarboxamide adenosine.
    Aran S; Proudfit HK
    Brain Res; 1990 Jun; 519(1-2):287-93. PubMed ID: 2397411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.